Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGILYSYS INC Director's Dealing 2023

Jun 15, 2023

31401_dirs_2023-06-14_60a3c947-ae58-48a5-b7c3-a5865e3e467d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGILYSYS INC (AGYS)
CIK: 0000078749
Period of Report: 2023-06-12

Reporting Person: Badger Kyle C (SVP, GC and Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-06-12 Common Stock M 16250 $0.00 Acquired 126333 Direct
2023-06-12 Common Stock M 14861 $0.00 Acquired 141194 Direct
2023-06-12 Common Stock F 16805 $74.28 Disposed 124389 Direct
2023-06-12 Common Stock S 5000 $74.11 Disposed 119389 Direct
2023-06-13 Common Stock S 5000 $72.86 Disposed 114389 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-06-12 Stock-settled Appreciation Rights $10.20 M 16250 Disposed 2024-07-06 Common Stock (16250) Direct
2022-06-12 Stock-settled Appreciation Rights $14.22 M 14861 Disposed 2025-05-31 Common Stock (14861) Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.80 to $74.55. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.93 to $73.48. The reporting person undertakes to provide to Agilysys, Inc., any security holder of Agilysys, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.

F3: Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.